Xiaoli Nie
Impact in
-
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Gut microbiota and health 5
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
-
- Ferroptosis and cancer prognosis 4
- Co-authors
- Te Liu (8 shared papers)Zixiang Geng (6 shared papers)Ren Luo (5 shared papers)Te Liu (2 shared papers)Jiajia Lin (5 shared papers)Haiyang Chen (2 shared papers)Lifen Xie (3 shared papers)Qi Xue (2 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)Annals of Translational Medicine (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Journal of Cancer (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoli Nie
40 papers receiving 645 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 94
- Nephrology 43
- Complementary and alternative medicine 29
- Reproductive Medicine 29
- Molecular Biology 247
Countries citing papers authored by Xiaoli Nie
This map shows the geographic impact of Xiaoli Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Nie more than expected).
Fields of papers citing papers by Xiaoli Nie
This network shows the impact of papers produced by Xiaoli Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Nie. The network helps show where Xiaoli Nie may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Nie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 49 | |
| 2 | 2020 | 47 | |
| 3 | 2022 | 45 | |
| 4 | 2022 | 41 | |
| 5 | 2004 | 39 | |
| 6 | 2023 | 37 | |
| 7 | 2016 | 31 | |
| 8 | 2016 | 30 | |
| 9 | 2020 | 27 | |
| 10 | 2022 | 25 | |
| 11 | 2022 | 25 | |
| 12 | Fisetin regulates gut microbiota to decrease CCR9+/CXCR3+/CD4+ T-lymphocyte count and IL-12 secretion to alleviate premature ovarian failure in mice. | 2020 | 24 |
| 13 | 2022 | 23 | |
| 14 | 2020 | 18 | |
| 15 | 2022 | 15 | |
| 16 | 2023 | 15 | |
| 17 | 2019 | 14 | |
| 18 | Catalpol alleviates renal damage by improving lipid metabolism in diabetic db/db mice. | 2018 | 13 |
| 19 | 2018 | 12 | |
| 20 | 2024 | 11 |
About Xiaoli Nie
Xiaoli Nie is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Rheumatology and Complementary and alternative medicine, having authored 40 papers that have together received 656 indexed citations. Recurring topics across this work include Gut microbiota and health (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Immune Cell Function and Interaction (2 papers) and Traditional Chinese Medicine Analysis (2 papers). The work is most often cited by research in Cancer Research (94 citations), Nephrology (43 citations), Complementary and alternative medicine (29 citations), Reproductive Medicine (29 citations) and Molecular Biology (247 citations). Xiaoli Nie has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Te Liu, Zixiang Geng, Ren Luo, Te Liu, Jiajia Lin, Haiyang Chen, Lifen Xie, Qi Xue, Jiulin Chen and Chuan Chen. Their work appears in journals such as Frontiers in Pharmacology, Annals of Translational Medicine, Oxidative Medicine and Cellular Longevity, Journal of Cancer and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.